Issn Print: 0923-7534
Publication Date: 2018/02/01
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial
L Ek; E Gezelius; B Bergman; P O Bendahl; H Anderson; J Sundberg; M Wallberg; U Falkmer; S Verma; M Belting
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.